Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.

about

Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.

Item

http://www.wikidata.org/entity/Q53397893

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Short-Term Response to Choline ...... ime to Nursing Home Placement.

@en

Short-Term Response to Choline ...... ime to Nursing Home Placement.

@nl

type

Item

label

Short-Term Response to Choline ...... ime to Nursing Home Placement.

@en

Short-Term Response to Choline ...... ime to Nursing Home Placement.

@nl

altLabel

Short-Term Response to Choline ...... Time to Nursing Home Placement

@en

prefLabel

Short-Term Response to Choline ...... ime to Nursing Home Placement.

@en

Short-Term Response to Choline ...... ime to Nursing Home Placement.

@nl

P1476

Short-Term Response to Choline ...... ime to Nursing Home Placement.

@en

P2093

Carina Wattmo

http://www.w3.org/2001/XMLSchema#string

P2860

Cholinesterase inhibitors for Alzheimer's disease

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil.

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.

Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort

Patient and caregiver characteristics and nursing home placement in patients with dementia.

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.

Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease.

P304

905-916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1567205015666180507105326

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lennart Minthon

Elisabet Londos

P577

2018-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29732972

http://www.w3.org/2001/XMLSchema#string

P932

6174634

http://www.w3.org/2001/XMLSchema#string